Heart Transplant Industry Outlook 2025-2029: Market Set to Cross $18.1 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

How Large Will the Heart Transplant Market Size By 2025?
The market size for heart transplants has seen swift expansion in the past few years. It's projected to escalate from $11.49 billion in 2024 to approximately $12.66 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.2%. The observed upward trend during the historic era is associated with progression in medical technology, heightened cognizance and education, advancements in the preservation of organs, and improvement in healthcare infrastructure.

How Big Is the Heart Transplant Market Size Expected to Grow by 2029?
The market size for heart transplants is anticipated to experience robust growth in the approaching years. Projected trends suggest an increase to $18.1 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. This surge during the prediction period can be linked to the support and funding provided by the government, the expansion of transplant initiatives globally, a rise in the capacity of transplant centers, and the incorporation of telemedicine and remote monitoring. Significant forecast period trends comprise advancements in technology, the use of artificial hearts and aid devices, as well as the application of artificial intelligence (AI) in the selection of donor organs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Which Key Market Drivers Powering Heart Transplant Market Expansion and Growth?
The surge in cardiovascular diseases is anticipated to bolster the heart transplant market's growth. These diseases encompass a variety of conditions impacting the heart and blood arteries. Heart transplantation serves as a final remedy for patients with end-stage heart failure who have not responded to other forms of treatment, enhancing their quality of life and longevity. The British Heart Foundation, a cardiovascular research charity based in the UK, reported in September 2024 that approximately 7.6 million people in the UK, including 4 million men and 3.6 million women, currently suffer from heart and circulatory diseases. Projections suggest that this number might increase by 1 million by 2030 and by 2 million more than current figures by 2040. Accordingly, the rise in cardiovascular diseases will stimulate the heart transplant market. Greater awareness regarding organ donation and transplantation is expected to fuel the heart transplant market's progression. This awareness factor indicates the degree of knowledge, comprehension, and alertness among individuals and communities about organ donation and transplantation's processes, importance, and effects on healthcare. An enhanced understanding of organ donation and transplantation has a profound effect on heart transplants by enlarging the donor pool, reducing the waiting period for recipients, and improving patient outcomes. As per the United Network for Organ Sharing, a non-profit scientific and educational organization in the US, a new annual record was set in January 2023 with 42,887 organ transplants, which marked a 3.7% increase from 2021. The growing awareness led to significant numbers of liver transplants with 9,528 procedures, heart transplants with 4,111 surgeries, and lung transplants with 2,692 operations. Therefore, the expansion of organ donation and transplantation awareness will steer the growth of the heart transplant market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Heart Transplant Market?
Leading organizations in the heart transplant market are progressively concentrating on creating novel solutions such as heart preservation technologies, with the goal of enhancing patient survival rates and transplant successfulness. This technology significantly increases the time a heart can be preserved outside the human body as compared to conventional ice storage methods, leading to improved results and fewer post-transplant complications. To illustrate, in May 2023, Xvivo Perfusion AB, a medical technology firm based in Sweden, obtained approval from the U.S. Food and Drug Administration (FDA) to apply their heart preservation technology as an Investigational Device Exemption (IDE). This paved the way for the commencement of the "PRESERVE Clinical Trial". This trial is an open-label, single-arm study, conducted in several locations, and designed to analyse the success of heart transplants following non-ischemic heart preservation from extended donors, specifically extending to Donation after Circulatory Death (DCD) hearts. The standout characteristic of XVIVO's heart preservation technology is its non-ischemic hypothermic perfusion system that uses chilled, oxygenated perfusion to keep the donor hearts preserved during transportation.

What Are the Emerging Segments in the Heart Transplant Market?
The heart transplant market covered in this report is segmented -

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types
2) By Transplant: Autograft, Allograft, Other Transplants
3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

Who Are the Global Leaders in the Heart Transplant Market?
Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Which are the Top Profitable Regional Markets for the Heart Transplant Industry?
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.